Navigation Links
Wall's To Develop Low-fat Ice-cream Using Fish Blood

Wall's have announced their plans to use a protein that has been originally isolated from fish blood to produce the world's first ice creams using genetically// modified technology.

The parent company, Unilever, have claimed that the technique will allow it them to develop ice creams that are of low-calorie, and low fat. They explained that they could be using this technology to make newer versions of their best selling products like the Cornetto, Magnum, and Carte D'Or.

There are debates going on about the GM technology due to an increased desire by consumers for a more natural 'real' food diet, where in artificial additives are removed. But officials at the Unilever believe the benefits of low-fat ice cream could prevail over any doubts about GM.

It was explained that the blood protein is originally extracted from an eel-like ocean pout fish, which uses the protein to survive extreme cold at the bottom of the seas. They stated that the protein has been chemically synthesised and it can be grown in vast vases that can produce a brownish liquid. This liquid, they explained could lower the lowers the temperatures at which ice crystals form and the shape they take up. They claimed that they could then create a stiff and solid mixture by using less cream or fat.

The company has also announced that they have submitted an application with the Food Standard Agency to use the new technology, involving the GM process. Unilever officials have also stated that the process has already been approved in the U.S. and in other parts of the world. They categorically stated that no GM material would remains in the final product, and that the process involving the GM element would be used to only create the protein.

Clare Oxborrow a food campaigner of the Friends of the Earth has said: 'At a time when more and more consumers want to choose unadulterated food, it's disappointing to see Unilever investing in this unnecessa ry development in overly processed food.'


'"/>




Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Risk Of Developing Arthritis
4. Developing HIV fighter
5. Missing Protein In Cancer Development
6. Tomatoes Might Inhibit the Development Of Prostate Cancer
7. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
8. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
9. Men Who at Risk Of Developing Prostate Cancer
10. Identifying The Risks Of Developing Schizophrenia
11. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... ... February 22, 2017 , ... Bellus Medical, ... latest innovation in the delivery of Platelet Rich Plasma (PRP). PRP systems are ... management, to accelerate tissue synthesis and provide a faster and more efficient healing ...
(Date:2/22/2017)... Athens, GA (PRWEB) , ... February 22, 2017 , ... ... Feb. 25 and 26 event in Athens, Georgia. , A shift from Super-Sod’s simple ... made in Georgia. , For the booth, grass seed plant manager Chris Roquemore constructed ...
(Date:2/22/2017)... ... February 22, 2017 , ... In ... many different solutions on the market, it is easy to start feeling frustrated ... Locksmith offers a complimentary security consultation. , Home Security Hardware Choices, There ...
(Date:2/21/2017)... Australia (PRWEB) , ... February 22, 2017 , ... Author ... it is valuable for every household and family to know all about it for ... publishing world with the release of “ Detox, Digestive and Wellness Solutions ” (published ...
(Date:2/21/2017)... ... February 21, 2017 , ... As recently as 2015, rhinoplasty was one of ... of Plastic Surgeons. Some patients want to make a change in the appearance of ... their breathing ability. The team at usrhinoplasty.org is expanding its article database ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 2017  Applied Silver, the maker of SilvaClean®, today announced ... advisory board. Ms. Barnes is the company,s third Clinical Advisor ... and healthcare experts Scott McNealy , Josh McQueen ... J. Tress Ritter , and Leopold Selker . ... than three decades of nationally recognized clinical, nursing, and infection ...
(Date:2/22/2017)... Feb. 22, 2017 Oncternal Therapeutics, Inc., ... both rare and common malignancies, today announced the ... The company intends to use the proceeds to ... and to advance preclinical development of a new ... is a first-in-class anti-ROR1 monoclonal antibody being developed ...
(Date:2/22/2017)... BEACH, Florida , February 22, 2017 /PRNewswire/ ... Cannabis Industries is becoming more and more prevalent ... Of Cannabinoids & THC Extracts as well as ... approach to medicinal cannabis and marijuana therapies and ... acquiring new relationships and assets designed to bring ...
Breaking Medicine Technology: